Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 29, 2026
DataAggregated Company Financials
Companies7
- 7D0.4%
- 3M-1.2%
- 1Y-43.0%
- YTDn/a
In the last week, the Clinical Research and Equipment industry is flat overall, with Diaceutics standing out by going down 4.5%. Unfortunately though, the industry is down 43% over the past 12 months. As for the next few years, earnings are expected to grow by 51% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1104.2x | -7.8x | 4x |
| Fri, 26 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1265.7x | -8.4x | 4.3x |
| Sun, 24 May 2026 | UK£1.5b | UK£318.9m | -UK£167,635,254.00 | n/a | -9x | 4.7x |
| Tue, 21 Apr 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.5x | 4.5x |
| Thu, 19 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10x | -8.7x | 4.4x |
| Sat, 14 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 10.9x | -9.7x | 5.1x |
| Mon, 12 Jan 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 8x | -9.9x | 5.2x |
| Wed, 10 Dec 2025 | UK£1.5b | UK£304.3m | -UK£160,776,254.00 | 6.1x | -9.1x | 4.8x |
| Fri, 07 Nov 2025 | UK£1.5b | UK£304.3m | -UK£163,156,254.00 | 8.3x | -9.3x | 5x |
| Sun, 05 Oct 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 9.4x | -10.6x | 5.7x |
| Tue, 02 Sep 2025 | UK£2.0b | UK£291.9m | -UK£160,968,352.00 | 6.3x | -12.5x | 6.9x |
| Thu, 31 Jul 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.5x | 7.4x |
| Sat, 28 Jun 2025 | UK£1.5b | UK£291.6m | -UK£159,942,352.00 | 7x | -9.5x | 5.2x |
| Mon, 26 May 2025 | UK£1.7b | UK£319.4m | -UK£190,818,893.50 | 10.9x | -8.7x | 5.2x |
| Wed, 23 Apr 2025 | UK£1.6b | UK£314.8m | -UK£185,541,707.50 | 6.4x | -8.5x | 5x |
| Fri, 21 Mar 2025 | UK£1.6b | UK£315.5m | -UK£186,120,020.75 | 6x | -8.4x | 4.9x |
| Sun, 16 Feb 2025 | UK£1.9b | UK£306.5m | -UK£195,236,961.36 | 7x | -9.6x | 6.1x |
| Tue, 14 Jan 2025 | UK£2.0b | UK£307.8m | -UK£196,243,287.12 | 6.4x | -10.3x | 6.6x |
| Thu, 12 Dec 2024 | UK£2.1b | UK£306.0m | -UK£194,846,724.24 | 8.6x | -10.8x | 6.9x |
| Sat, 09 Nov 2024 | UK£1.9b | UK£304.9m | -UK£192,889,229.20 | 10.6x | -9.8x | 6.2x |
| Mon, 07 Oct 2024 | UK£2.1b | UK£304.3m | -UK£192,222,280.30 | 10.8x | -10.7x | 6.8x |
| Wed, 04 Sep 2024 | UK£1.9b | UK£293.9m | -UK£192,979,386.80 | 12.3x | -9.8x | 6.4x |
| Fri, 02 Aug 2024 | UK£1.9b | UK£295.7m | -UK£190,095,307.26 | 12.6x | -9.8x | 6.3x |
| Sun, 30 Jun 2024 | UK£1.5b | UK£296.0m | -UK£190,325,313.69 | 11.4x | -7.8x | 5x |
| Tue, 28 May 2024 | UK£1.7b | UK£295.6m | -UK£189,783,687.99 | 11.3x | -8.7x | 5.6x |
| Thu, 25 Apr 2024 | UK£1.6b | UK£317.7m | -UK£178,535,879.90 | 12x | -8.7x | 4.9x |
| Sat, 23 Mar 2024 | UK£1.8b | UK£296.0m | -UK£213,289,739.77 | 7353.2x | -8.6x | 6.2x |
| Mon, 19 Feb 2024 | UK£2.1b | UK£286.0m | -UK£189,371,602.11 | 6964.1x | -11x | 7.3x |
| Wed, 17 Jan 2024 | UK£2.9b | UK£450.2m | -UK£174,196,187.00 | 62.5x | -16.6x | 6.4x |
| Fri, 15 Dec 2023 | UK£3.0b | UK£452.4m | -UK£170,292,194.00 | 53x | -17.7x | 6.7x |
| Sun, 12 Nov 2023 | UK£3.0b | UK£456.4m | -UK£169,438,000.00 | 47.7x | -17.7x | 6.6x |
| Tue, 10 Oct 2023 | UK£2.8b | UK£458.5m | -UK£165,462,893.00 | 53.6x | -17.2x | 6.2x |
| Thu, 07 Sep 2023 | UK£3.1b | UK£476.7m | -UK£126,971,741.00 | 69.6x | -24.3x | 6.5x |
| Sat, 05 Aug 2023 | UK£3.4b | UK£476.4m | -UK£124,645,721.00 | 70.6x | -27.2x | 7.1x |
Price to Earnings Ratio
-27.2x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 2.40% | |
| Healthcare | 4.41% | |
| Life Sciences | 0.35% | |
| Clinical Research and Equipment | 0.35% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.12 | 0.6% +UK£6.8m | -44.4% | PS4.9x | |
| HVO hVIVO | UK£0.072 | 7.4% +UK£3.4m | -27.5% | PS1x |